|
|
| Line 1: |
Line 1: |
| | | | |
| | ==Structure of C3-binding domain 4 of Staphylococcus aureus protein Sbi== | | ==Structure of C3-binding domain 4 of Staphylococcus aureus protein Sbi== |
| - | <StructureSection load='2jvg' size='340' side='right'caption='[[2jvg]], [[NMR_Ensembles_of_Models | 20 NMR models]]' scene=''> | + | <StructureSection load='2jvg' size='340' side='right'caption='[[2jvg]]' scene=''> |
| | == Structural highlights == | | == Structural highlights == |
| - | <table><tr><td colspan='2'>[[2jvg]] is a 1 chain structure with sequence from [https://en.wikipedia.org/wiki/"micrococcus_aureus"_(rosenbach_1884)_zopf_1885 "micrococcus aureus" (rosenbach 1884) zopf 1885]. Full experimental information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2JVG OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=2JVG FirstGlance]. <br> | + | <table><tr><td colspan='2'>[[2jvg]] is a 1 chain structure with sequence from [https://en.wikipedia.org/wiki/Staphylococcus_aureus Staphylococcus aureus]. Full experimental information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2JVG OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=2JVG FirstGlance]. <br> |
| - | </td></tr><tr id='related'><td class="sblockLbl"><b>[[Related_structure|Related:]]</b></td><td class="sblockDat"><div style='overflow: auto; max-height: 3em;'>[[2gom|2gom]], [[2noj|2noj]], [[2qff|2qff]], [[2jvh|2jvh]]</div></td></tr> | + | </td></tr><tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=2jvg FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=2jvg OCA], [https://pdbe.org/2jvg PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=2jvg RCSB], [https://www.ebi.ac.uk/pdbsum/2jvg PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=2jvg ProSAT]</span></td></tr> |
| - | <tr id='gene'><td class="sblockLbl"><b>[[Gene|Gene:]]</b></td><td class="sblockDat">sbi ([https://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&srchmode=5&id=1280 "Micrococcus aureus" (Rosenbach 1884) Zopf 1885])</td></tr>
| + | |
| - | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=2jvg FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=2jvg OCA], [https://pdbe.org/2jvg PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=2jvg RCSB], [https://www.ebi.ac.uk/pdbsum/2jvg PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=2jvg ProSAT]</span></td></tr> | + | |
| | </table> | | </table> |
| | == Function == | | == Function == |
| - | [[https://www.uniprot.org/uniprot/SBI_STAAN SBI_STAAN]] Interacts with components of both the adaptive and innate host immune system, thereby protecting the cell against the host immune response.
| + | [https://www.uniprot.org/uniprot/SBI_STAAM SBI_STAAM] Plays a role in the inhibition of both the innate and adaptive immune responses. Possesses two N-terminal domains that bind the Fc region of IgG and two domains that form a tripartite complex with complement factors C3b and CFH. By recruiting CFH and C3b, the secreted form acts as a potent complement inhibitor of the alternative pathway-mediated lysis.[UniProtKB:A6QJQ7]<ref>PMID:18550524</ref> |
| | <div style="background-color:#fffaf0;"> | | <div style="background-color:#fffaf0;"> |
| | == Publication Abstract from PubMed == | | == Publication Abstract from PubMed == |
| Line 24: |
Line 22: |
| | </StructureSection> | | </StructureSection> |
| | [[Category: Large Structures]] | | [[Category: Large Structures]] |
| - | [[Category: Bagby, S]] | + | [[Category: Staphylococcus aureus]] |
| - | [[Category: Burman, J]] | + | [[Category: Bagby S]] |
| - | [[Category: Clark, E A]] | + | [[Category: Burman J]] |
| - | [[Category: Elsen, J M.H van den]] | + | [[Category: Clark EA]] |
| - | [[Category: Upadhyay, A]] | + | [[Category: Upadhyay A]] |
| - | [[Category: Immune system]] | + | [[Category: Van den Elsen JMH]] |
| - | [[Category: Three helix bundle]]
| + | |
| Structural highlights
Function
SBI_STAAM Plays a role in the inhibition of both the innate and adaptive immune responses. Possesses two N-terminal domains that bind the Fc region of IgG and two domains that form a tripartite complex with complement factors C3b and CFH. By recruiting CFH and C3b, the secreted form acts as a potent complement inhibitor of the alternative pathway-mediated lysis.[UniProtKB:A6QJQ7][1]
Publication Abstract from PubMed
Among the recently discovered Staphylococcus aureus immune evasion proteins, Sbi is unique in its ability to interact with components of both the adaptive and innate immune systems of the host. Sbi domains I and II (Sbi-I and Sbi-II) bind IgG. Sbi domain IV (residues 198-266) binds the central complement protein C3. When linked to Sbi-III, Sbi-IV induces a futile consumption of complement via alternative pathway activation, whereas isolated Sbi-IV specifically inhibits the alternative pathway without complement consumption. Here we have determined the three-dimensional structure of Sbi-IV by NMR spectroscopy, showing that Sbi-IV adopts a three-helix bundle fold similar to those of the S. aureus complement inhibitors Efb-C, Ehp, and SCIN. The (1)H-(15)N HSQC spectrum of Sbi-III indicates that this domain, essential for futile complement consumption, is natively unfolded, at least when isolated from the rest of Sbi. Sbi-IV and Sbi-III-IV both bind C3dg with 1:1 stoichiometry and submicromolar affinity. Despite low overall sequence identity, Sbi possesses the same residues as Efb at two positions essential for Efb-C binding to C3d. Mutation to alanine of either of these residues, Arg-231 and Asn-238, abolishes both Sbi-IV binding to C3dg and Sbi-IV alternative pathway inhibition. The almost complete conservation of Sbi-III and Sbi-IV amino acid sequences across more than 30 strains isolated from human and animal hosts indicates that the unique mechanism of Sbi in complement system subversion is a feature of infections of both humans and economically important animals.
Structure-function analysis of the C3 binding region of Staphylococcus aureus immune subversion protein Sbi.,Upadhyay A, Burman JD, Clark EA, Leung E, Isenman DE, van den Elsen JM, Bagby S J Biol Chem. 2008 Aug 8;283(32):22113-20. Epub 2008 Jun 11. PMID:18550524[2]
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
References
- ↑ Upadhyay A, Burman JD, Clark EA, Leung E, Isenman DE, van den Elsen JM, Bagby S. Structure-function analysis of the C3 binding region of Staphylococcus aureus immune subversion protein Sbi. J Biol Chem. 2008 Aug 8;283(32):22113-20. Epub 2008 Jun 11. PMID:18550524 doi:10.1074/jbc.M802636200
- ↑ Upadhyay A, Burman JD, Clark EA, Leung E, Isenman DE, van den Elsen JM, Bagby S. Structure-function analysis of the C3 binding region of Staphylococcus aureus immune subversion protein Sbi. J Biol Chem. 2008 Aug 8;283(32):22113-20. Epub 2008 Jun 11. PMID:18550524 doi:10.1074/jbc.M802636200
|
